Uraguay

 

Mubadala-backed M42 buying Diaverum “for $2bn+”

Swedish multinational dialysis firm Diaverum is being bought by M42, a joint venture between Abu Dhabi sovereign wealth fund Mubadala Investment Co and AI firm G42, for a reported $2bn-$2.5bn. Diaverum’s CEO tells HBI the deal offers further opportunities to develop its digital strategies, and international expansion. 

Diaverum deal: An analysis

Last week the news broke that Abu Dhabi sovereign wealth fund Mubadala Investment Co might be set to buy Swedish multinational dialysis firm Diaverum for a reported $2.5bn. HBI speaks to an operator source who thinks this would be a good price for the seller - and hears why some investors are switched off by dialysis.

DomusVi acquires in Chile and targets Peru and Mexico

European nursing home operator DomusVi has acquired two facilities in Chile through its subsidiary Acalis as part of a rapid expansion strategy across the region. This is the group's second acquisition in Latin America, as growth has otherwise been focused on greenfield. We speak to the CEO of Acalis Latam about the group's regional strategy.

DomusVi appoints new CEO

Europe's third-largest nursing home group by revenue, DomusVi, has appointed a new CEO with no healthcare services management experience. He is the group's third CEO in the space of a year.

Interview: Dimitris Moulavasilis, CEO, Diaverum 

Will international dialysis group Diaverum IPO or sell? We catch up with its new CEO, the former boss of international imaging group Affidea. Rarely have we met such an enthusiastic leader. That may be just as well. Many wonder whether Diaverum, which has been owned by private equity house Bridgepoint since 2007, can ever be sexed up enough to attract a top price. If anyone can achieve this, it is Moulavasilis. 

Opportunities in LATAM

Panellists on the LatAm panel at HBI 2019 see good opportunities in the region thanks to booming demand, particularly as demographics shift from rural to urban bases, and with the growth of the chronic and elderly care markets. Increasing use of digital health tools and better data, plus the growth of the consumer market are also seen as positive factors for the market.

Orpea advances in Latin America

Orpea, Europe's second-largest nursing home operator by revenue, has made big strides in Latin America, with acquisitions in Chile, Brazil and Uruguay in 2018. We speak to a market expert about its expansion, with a focus on Brazil, and its full-year results published this week.

Find Us